The complex relationship among arteriovenous access, heart, and circulation.

Area of Science:

• Nephrology
• Cardiology
• Vascular Surgery

Background:

• Over 400,000 patients in the US undergo hemodialysis, with >50% mortality from cardiovascular events.
• Most hemodialysis patients utilize arteriovenous fistulas (AVFs) for vascular access.
• AVFs are linked to adverse cardiac function, but their precise role in cardiovascular morbidity requires clarification.

Discussion:

• High-flow AVFs can lead to high-output heart failure, a known complication.
• Paradoxically, AVFs may offer cardiopulmonary benefits in conditions like severe COPD.
• The fundamental AVF concept saves lives, yet managing high blood flow rates remains challenging.

Key Insights:

• AVF blood flow rates are difficult to accurately evaluate.
• The direct contribution of AVFs to cardiovascular morbidity is not fully understood.
• Balancing the benefits and risks of AVF hemodynamics is critical for patient outcomes.

Outlook:

• Further research is needed to develop reliable methods for evaluating AVF flow rates.
• Improved strategies for managing AVF hemodynamics could reduce cardiovascular complications.
• Optimizing AVF management may enhance survival rates for hemodialysis patients.